Gene polymorphisms of cyclin‐dependent kinase inhibitor and matrix metalloproteinase‐9 in Sudanese patients with esophageal squamous cell carcinoma
Open Access
- 19 October 2022
- journal article
- research article
- Published by Wiley in Molecular Genetics & Genomic Medicine
- Vol. 10 (12) , e2074
Abstract
Background: The polymorphisms of the cyclin‐dependent kinase inhibitor (CDKN1A) gene and matrix metalloproteinase‐9 (MMP9) gene may increase one's susceptibility to malignancies. In this study, the association of the single nucleotide polymorphisms (SNPs) CDKN1A rs1059234 c.70C>T at the 3′ untranslated region and MMP9 rs17576 (c.836A>G, p.Gln279Arg) with esophageal squamous cell carcinoma (ESCC) in Sudanese individuals were investigated.Materials and Methods: A case‐control study involving age‐ and gender‐matched groups were conducted in a cancer center in eastern Sudan (Gadarif) between April and October 2020. The case group consisted of ESCC patients, whereas the control group comprised healthy subjects. Polymerase chain reaction‐restriction fragment length polymorphism was performed for the genotyping of the CDKN1A rs1059234 and MMP9 rs17576 SNPs. The genotyping results were confirmed by Sanger sequencing.Results: The genotype distributions for CDKN1A rs1059234 and MMP9 rs17576 were in agreement with the Hardy–Weinberg equilibrium. The variant allele T in CDKN1 rs1059234 c.70C>T was significantly more prevalent in the ESCC patients than in the healthy controls [51.3% vs. 19.2%; OR = 4.4; 95% CI (2.6–7.4); p < 0.001]. Moreover, in CDKN1A rs1059234, the genotype TC + TT [76.9% vs. 38.4%; OR = 5.3; 95% CI (2.6–10.7); p < 0.001] was more frequent in the cases than in the controls, and it was significantly associated with ESCC risk. In MMP9 rs17576, the variant allele G was also significantly prevalent in the cases relative to the controls, and it was significantly associated with increased ESCC risk in the cases compared with the controls [27.5% vs. 1.9%; OR = 19.4; 95%CI (5.8–64.1); p < 0.001]. Both genotypes containing the allele G (AG + GG) were the most common genotypes in the cases [48.7% vs. 3.8%; OR = 23.7; 95%CI (6.8–81.7); p < 0.001], and they significantly increased the risk of ESCC.Conclusion: A significant increase in ESCC risk is associated with the SNPs CDKN1A rs1059234 and MMP9 rs17576.Keywords
This publication has 32 references indexed in Scilit:
- Cancer incidence in Khartoum, Sudan: first results from the Cancer Registry, 2009–2010Cancer Medicine, 2014
- Preeclampsia Is Associated with Alterations in the p53-Pathway in Villous TrophoblastPLOS ONE, 2014
- Matrix metalloproteinase-9 overexpression is closely related to poor prognosis in patients with colon cancerWorld Journal of Surgical Oncology, 2014
- Association of Genetic Polymorphisms in Matrix Metalloproteinase-9 and Coronary Artery Disease in the Chinese Han Population: A Case–Control StudyGenetic Testing and Molecular Biomarkers, 2013
- Genetic polymorphism of matrix metalloproteinases in breast cancerNeoplasma, 2012
- Environmental Causes of Esophageal CancerGastroenterology Clinics of North America, 2009
- Associations of Matrix Metalloproteinase-9 Protein Polymorphisms with Lymph Node Metastasis but not Invasion of Gastric CancerClinical Cancer Research, 2008
- Genetic polymorphisms of p21 are associated with risk of squamous cell carcinoma of the head and neckCarcinogenesis, 2005
- Defining a novelciselement in the 3′-untranslated region of mammalian ribonucleotide reductase component R2 mRNA: role in transforming growth factor-β1induced mRNA stabilizationNucleic Acids Research, 1995
- WAF1, a potential mediator of p53 tumor suppressionCell, 1993